Valuation: Illumina, Inc.

Market Cap 29.25B 25.38B 23.77B 21.74B 41.05B 2,786B 41.58B 278B 109B 1,392B 110B 107B 4,634B P/E 2026 *
38.7x
P/E 2027 * 33.2x
Enterprise Value 29.5B 25.6B 23.97B 21.93B 41.39B 2,810B 41.93B 280B 110B 1,404B 111B 108B 4,673B EV / Sales 2026 *
6.38x
EV / Sales 2027 * 5.81x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.74%
1 week-7.73%
Current month-7.73%
1 month-1.31%
3 months+36.44%
6 months+61.41%
Current year+44.29%
1 week 187.05
Extreme 187.05
207
1 month 178.88
Extreme 178.88
207
Current year 112.65
Extreme 112.65
207
1 year 88
Extreme 88
207
3 years 68.7
Extreme 68.7
207
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
30/07/26 Sell

General Counsel

-615 0.0004%
30/06/26 Free

Director

167 0.0001%
30/06/26 Free

Director

142 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.75%-7.73%+98.17%+1.08% 29.25B
+0.97%+1.76%+28.52%+5.91% 214B
+1.25%+3.57%+1.74%-21.00% 141B
+1.38%+7.00%-19.53%+22.26% 132B
+1.08%+6.46%-51.68%-1.93% 71.45B
+0.88%+4.30%+15.20%+12.44% 51.48B
+1.13%+7.38%-14.27%-18.88% 50.15B
+1.57%+3.45%+25.58%+13.15% 39.92B
+0.32%+6.40%+44.41%+38.57% 39.24B
-5.31%+0.44%-24.37%+13.52% 32.2B
Average -0.01%+3.29%+10.38%+6.51% 80.08B
Weighted average by Cap. +0.63%+3.09%+6.25%+4.14%

Financials

2026 *2027 *
Net sales 4.62B 4.01B 3.76B 3.44B 6.49B 440B 6.57B 43.96B 17.25B 220B 17.36B 16.98B 732B 4.91B 4.26B 3.99B 3.65B 6.89B 468B 6.98B 46.66B 18.31B 234B 18.43B 18.03B 778B
Net income 771M 669M 626M 573M 1.08B 73.41B 1.1B 7.33B 2.88B 36.68B 2.89B 2.83B 122B 889M 772M 723M 661M 1.25B 84.72B 1.26B 8.45B 3.32B 42.33B 3.34B 3.27B 141B
Net Debt 246M 213M 200M 183M 345M 23.44B 350M 2.34B 918M 11.71B 924M 904M 38.97B -729M -633M -592M -542M -1.02B -69.44B -1.04B -6.93B -2.72B -34.7B -2.74B -2.68B -115B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
07/08/26 US$189.33 -2.27% 241,469
06/08/26 US$193.72 -3.08% 4,276,169
05/08/26 US$199.87 -1.55% 2,266,096
04/08/26 US$203.01 +2.45% 3,104,446
03/08/26 US$198.16 -3.38% 2,612,022
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
193.72USD
Average target price
195.83USD
Spread / Average Target
+1.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock